ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,488Medicare Part D Prescriptions Filled, Including Refills

Rank: 222 out of 1000

$615K Total Retail Price of All Prescriptions

Rank: 187 out of 1000

590 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 590 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

22% of this provider’s 590 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

2% of this provider’s 8,372 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 637 329 S3 1 1
OMEPRAZOLE 362 274 2 2
SIMVASTATIN 335 292 3 3
ZOLPIDEM TARTRATE 333 188 4 16
LISINOPRIL 303 237 5 5
LEVOTHYROXINE SODIUM 277 219 6 4
AMLODIPINE BESYLATE 254 217 7 6
MELOXICAM 248 193 8 14
METFORMIN HCL 229 184 9 8
CARVEDILOL 203 153 10 15
SERTRALINE HCL 199 168 11 26
LISINOPRIL-HYDROCHLOROTHIAZIDE 184 154 12 20
POTASSIUM CHLORIDE 178 136 13 10
FUROSEMIDE 176 133 14 7
HYDROCHLOROTHIAZIDE 174 139 15 9
WARFARIN SODIUM 168 139 16 22
NEXIUM 160 150 17 23
CITALOPRAM HBR 159 126 18 17
AMLODIPINE BESYLATE-BENAZEPRIL 159 108 18 59
GABAPENTIN 150 94 20 11
TRAMADOL HCL 140 134 21 13
ATENOLOL 128 97 22 24
TAMSULOSIN HCL 123 112 23 33
PANTOPRAZOLE SODIUM 123 79 23 28
ATORVASTATIN CALCIUM 118 98 25 18
LYRICA 115 85 26 47
METOPROLOL SUCCINATE 108 89 27 21
PAROXETINE HCL 106 68 28 63
PRAVASTATIN SODIUM 102 94 29 12
CYCLOBENZAPRINE HCL 94 37 R 30 39
GLIMEPIRIDE 92 73 31 34
SYNTHROID 90 66 32 91
BENAZEPRIL HCL 88 83 33 61
LEVOFLOXACIN 87 55 34 73
DIOVAN 84 76 35 67
PREDNISONE 82 60 36 42
LOSARTAN-HYDROCHLOROTHIAZIDE 76 74 37 38
NAMENDA 75 68 38 43
ADVAIR DISKUS 68 36 39 65
DIGOXIN 68 68 39 52
PREMARIN 67 35 R 41 109
CEFDINIR 67 45 41 122
FENOFIBRATE 66 51 43 55
DONEPEZIL HCL 65 62 44 32
SPIRIVA 65 43 44 64
CARISOPRODOL 63 0 R 46 72
CLOPIDOGREL 63 47 46 35
LOVASTATIN 62 45 48 41
CYMBALTA 58 26 49 53
KLOR-CON 10 58 52 49 104
CIPROFLOXACIN HCL 58 45 49 46
PROAIR HFA 57 29 52 50
TRIAMTERENE-HCTZ 57 46 52 48
FLUCONAZOLE 56 34 54 102
ALLOPURINOL 55 50 55 31
RAMIPRIL 54 45 56 77
OXYCODONE HCL 53 0 S2 57 118
TRAZODONE HCL 53 37 57 29
FLUTICASONE PROPIONATE 53 30 57 40
OXYCONTIN 51 19 S2 60 166
FENTANYL 51 27 S2 60 100
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 14, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.